Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
4,947 total articles
Block, Inc. Ecosystem Lead Brian Grassadonia sold 1,769 shares of Class A Common Stock on April 6, 2026, at $60.25 per share for a total of $106,582. Following the sale Grassadonia retains direct ownership of 500,763 shares. The stock has risen since the trade to $62.83, but remains down 23% over the prior six months. The transaction was carried ou…
Todd Krasnow, a director of Symbotic Inc (SYM), sold 2,000 shares of Class A common stock on April 6, 2026, for a total of $106,544 and completed a related unit redemption that swapped 2,000 Class V-1 shares for 2,000 Class A shares under a pre-arranged plan. The transactions came as the stock traded at $54.55, a price level that reflects a 205% ga…
Root, Inc. Chief Administrative Officer Jonathan Allison sold 1,706 shares of Class A common stock on April 7, 2026, under a pre-arranged 10b5-1 plan, generating roughly $75,661. The share price has since moved to $46.44 but remains about 57% below its level a year earlier. Allison retains direct ownership of 71,668 shares. Separately, Root reporte…
John W. Swygert, executive chairman of Ollie’s Bargain Outlet Holdings, sold 3,330 shares on April 7, 2026 under a Rule 10b5-1 plan. The transaction totaled $319,014 and leaves Swygert with 48,200 shares. The stock trades near the top of his sale range while analysts weigh the company's recent quarterly comparable-sales performance and a planned me…
A director of Circle Internet Group, Inc. sold 1,666 Class A shares on April 6, 2026, for a total of $153,905 under a pre-arranged 10b5-1 trading plan. The weighted average sale price was $92.38 per share; the shares were sold between $91.81 and $92.78. After the transaction the director directly holds 341,872 shares. The sale occurred while CRCL t…
Rush Street Interactive Chief Financial Officer Kyle Sauers sold 23,000 shares of the company's Class A common stock on April 6, 2026, for $22.62 per share, a transaction totaling $520,260, according to a Form 4 filing with the SEC. The sale was carried out under a pre-arranged 10b5-1 trading plan. The move comes while RSI stock is trading close to…
Rush Street Interactive (NASDAQ: RSI) Chief Legal Officer Paul Wierbicki sold 15,000 Class A shares on April 8, 2026, for roughly $345,019, transacting at prices between $23 and $23.05. The sale, executed under a 10b5-1 trading arrangement, occurred near the stock's 52-week high and follows a 110% rally over the past year. Analysts continue to assi…
Bakkt, Inc. Chief Operating Officer Nicholas Baes sold 711 shares of Class A common stock on April 6, 2026, to satisfy tax obligations tied to vested restricted stock units. The transaction totaled $5,375. The company has also priced a registered direct offering expected to raise about $48.1 million, set up a $300 million at-the-market equity progr…
Director Rajeev V. Date sold 3,819 shares of Circle Internet Group Class A stock on April 6 and April 7, 2026, for $357,687 under a pre-arranged 10b5-1 plan, while exercising options to acquire the same number of shares at $0.08 each. The transactions were disclosed in a Form 4 filing. The company has also rolled out a managed stablecoin settlement…
Airbnb director Joseph Gebbia sold $7,317,455 of Class A common stock on April 6, 2026 under a Rule 10b5-1 trading plan. The disposals encompassed multiple transactions across a range of prices; the company recently completed a $2.5 billion senior notes offering used to repay $2.0 billion of convertible senior notes. Analysts issued a mixture of ou…
Alignment Healthcare Chief Financial Officer James M. Head sold 11,100 shares on April 7, 2026, at $21.08 per share to satisfy tax-withholding obligations related to vested restricted stock units. The transaction, disclosed on a Form 4 filing with the Securities and Exchange Commission, was not a discretionary sale. Alignment Healthcare recently re…
Longevity Health Holdings Chief Executive Ajjarapu J. Ram reported an insider purchase of 689,656 common shares on March 16, 2026, at $0.29 per share, representing roughly $200,000. The transaction is recorded as indirect ownership by International Capital Partners LLC. The company's shares are trading near $0.27, reflecting weekly and annual decli…
Alignment Healthcare Chief Executive John E. Kao sold 250,000 shares on April 7, 2026, realizing roughly $5.25 million across two trades conducted under a pre-arranged Rule 10b5-1 plan. The sales occurred as ALHC shares climbed about 19.5% over the prior week, while the company reported robust fourth-quarter metrics and disclosed a General Atlantic…
Norman Prestage, a director at Lamb Weston Holdings, purchased 2,500 shares on April 7, 2026 for $41.40 each, a $103,500 transaction recorded on a Form 4 filing. The purchase increases his direct holdings to 9,481.7 shares. The move comes after a 34% fall in the stock over six months and amid updated fiscal 2026 guidance lifting midpoint revenue an…
Verisign Executive Vice President, General Counsel, and Secretary Thomas C. Indelicarto sold 498 shares of Verisign stock on April 7, 2026, for $136,452. The transaction coincides with a recent 8% one-week stock rise and third-party analysis that places the company on an overvalued list. The company’s reported fourth-quarter 2025 results showed a r…
Photronics INC director Lee Kang Jyh sold 5,000 shares on April 6, 2026, after exercising 5,000 stock options. The transactions occurred as the company reported fiscal Q1 2026 results that beat expectations and announced the installation of a new mask writer in Korea, while the stock trades notably higher year-over-year.
Mark Elliott Boulding, Executive Vice President and Chief Legal Officer of PTC Therapeutics (PTCT), sold 2,265 shares on April 6, 2026, in transactions totaling $157,293 and exercised options to acquire the same number of shares at $39.42. Following the activity, Boulding holds 105,212 shares. The trades were carried out under a pre-arranged plan a…
MediaAlpha, Inc. (NASDAQ: MAX) Chief Executive Steven Yi sold 12,000 shares of Class A common stock across three trades from April 6 to April 8, 2026, totaling about $114,335. The sales were carried out under a Rule 10b5-1 trading plan to cover taxes from RSU vesting. The company recently reported fourth-quarter 2025 revenue of $291 million, below …
Entegris Inc. (NASDAQ: ENTG) General Counsel Joseph Colella sold 1,592 shares on April 7, 2026, in a transaction worth $183,987 under a Rule 10b5-1 plan. The stock has since risen to $129.60, representing a 41% year-to-date gain and an 89% return over the prior 12 months. Entegris also reported Q4 2025 results that topped expectations, prompting BM…
Mat Ishbia and SFS Holding Corp., a greater-than-10% stakeholder in UWM Holdings Corp., sold a combined 2,001,148 shares of Class A common stock on April 7 and April 8, 2026, in two transactions totaling roughly $7.48 million. The trades were executed under a 10b5-1 trading plan. The disclosures come as UWM reports stronger-than-expected fourth-qua…
Director Laurie Harris sold 5,531 shares of Hagerty, Inc. Class A common stock on April 7, 2026, through an automatic trading arrangement established in November 2025. The sale, which generated roughly $60,896, followed restricted stock unit vesting and leaves Harris with 36,689 shares. Hagerty recently reported Q4 2025 results that exceeded analys…
EverCommerce Inc. President Matthew David Feierstein sold 15,000 shares on April 6 and 7, 2026, for proceeds of $175,970 under a Rule 10b5-1 plan. The company recently reported fourth-quarter 2025 results that included an EPS of $0.03 versus an expected $0.05 and revenue of $151.2 million versus a $150.36 million forecast. At a market price of $11.…
The Hershey Trust Co., acting as trustee for the Milton Hershey School, disclosed the sale of common shares in The Hershey Co. on April 6, 7 and 8, 2026. The filings show sales totaling roughly $6.2 million at prices between $205.45 and $208.5732. Following the transactions the trust's direct and indirect holdings were reported, and recent analyst …
Avalo Therapeutics Chief Medical Officer Doyle Mittie sold 3,970 shares on April 6, 2026, for about $71,508, after exercising options for the same number of shares at $12.65 each. The transactions were carried out under a Rule 10b5-1 plan. Meanwhile, several analysts reiterated or initiated Buy/Outperform ratings and adjusted price targets as the c…
Jeffrey W. Priest, President and CEO of General American Investors Co Inc (GAM), purchased 5,000 shares of the company's 5.95% preferred stock on April 8, 2026, paying $24.685 per share for a total of $123,425. The transaction was recorded as a purchase of Non-Derivative Securities and raises his direct preferred-stock holdings to 40,691 shares. Pr…
